| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |